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INTRODUCTION
Though the United States is one of the most prosperous nations in the world,
many preventable health problems still plague its people. Obesity, AIDS, diabetes, and
heart disease affect millions in the U.S., but there seems to be no other affliction that
carries with it as much fear and dread as cancer. Breast cancer is the second most
prevalent cancer among American women, preceded only by skin cancer, as well as the
second most deadly, surpassed only by lung cancer. While not as common, cervical
cancer continued to strike and kill thousands of women in the U.S. each year as well.
Both of these cancers are greatly feared not only because of their mortality rates, but also
because of the personal and intimate nature of the bodily areas they attack. However,
both of these cancers are highly treatable and curable when they are discovered in their
early stages. Two screening procedures used for early detection of these cancers,
mammograms and Papanicolaou smear tests, are revered for their life-saving value and
have been in widespread use in America’s health care system for decades. But there
remain thousands of women who have never received mammograms or Papanicolaou
smear tests, and there is an even greater number of women who have had these clinical
preventive services at some point in their lives, but do not continue to do so at regular,
timely intervals. What differences separate those women who utilize mammography and
Pap tests and those who do not? What factors can best be used to predict those women
who will not obtain breast and cervical cancer screenings at regular, timely intervals?
Many studies have focused on these questions, and specific patterns have emerged from
the research. However, we first should examine the background context of such
questions by recalling the history of women’s health.
BACKGROUND
Histm:y ofthe Women’s Health Movement
The term "women’s health" has a long and varied history in the health care
system of the United States. For some people, whether or not they are trained in the
medical sciences, women’s health is essentially a synonym for female reproductive health
services, revolving around a woman’s childbearing capacities and consisting mostly of
pelvic examinations and prenatal care. We can see the tying of women’s health to
reproductive functions as far back as the late 1800s, when partial justifications were made
for legislative policies prohibiting abortion and contraception on the basis of the
preservation of women’s health and their maternal role.2 The enduring reproduction-
centered view of women’s health, focusing on women as mothers or potential mothers, is
further evidenced by the merging of the areas of obstetrics and gynecology into a single
medical specialty in 1930. However, this mainstream view of women’s health in the late
nineteenth and early twentieth centuries did not go unchallenged for long. In her 1998
book entitled Women’s Health Care." Activist Traditions and Institutional Change,4 Carol
Weisman describes three major periods of women’s health activism that pushed health
care professionals and society at large to extend their view of women’s health beyond
maternal matters. These periods include:
1) The Progressive Era from 1890- 1930: In this period came the increasing
demand for expanded maternal and child health services, which became official
public policy through the creation of the Children’s Bureau at the U.S.
Department of Labor in 1912 and the passage of the Sheppard-Towner Maternity
and Infancy Act of 1921. Additionally, this era saw the emergence of birth
control advocates, who emphasized the need for mamed women to exercise
control over their reproductive and sexual lives. This notion was met with
resistance by medical professionals, laypersons, and maternal and child health
advocates as well, causing a rift in the women’s health movement of this era.
2) The Women’s Health Movement of the 1960s and 1970s: Political turmoil and
social unrest extended into the realm of health care during this period, and
women’s health advocates rebuked the male-dominated and medicine-based
system that characterized health care and health information services. It was also
a time when reproduction-centered women’s health was seriously challenged, as
women demanded increasingly more control over their maternal status and no
longer viewed childbearing and childrearing as essential and integral parts of their
lives. Specifically, with the advent of the oral contraceptive pill and the
legalization of surgical abortion, women had more viable options for controlling
their reproductive functions.
3) Women’s Health Advocacy in the 1990s" As more women attained positions of
influence within the government, educational institutions, the judicial system, and
health care organizations, they continued to support the fights of females to
control their own reproductive lives by trying to curtail bamers to abortion
services and by exposing the need for more effective contraceptive options for
women. These advocates also shed light on other women’s health concerns,
including women’s health care within a gender-based social context, the need for
a larger number of females to be studied in medical research, and the need for
more emphasis on the lifespan view of women’s health.
The culmination of these three periods in the women’s health movement resulted
in the Breast and Cervical Cancer Mortality Prevention Act of 1990, from which emerged
the Centers for Disease Control and Prevention’s Breast and Cervical Cancer Early
Detection Program. This program, which is still ongoing, aims to increase access to
mammography and Pap test screenings for underserved women. From the
aforementioned periods of women’s health activism also came the increase in federal
funding for breast cancer research to $500 million in 1995 (up from $90 million in
1991),4 and the establishment of the Women’s Health Initiative, which focuses on midlife
and older women’s health issues, and is the largest research study ever funded by the
National Institutes of Health.s Offices of Women’s Health were established at the U.S.
Department of Health and Human Services (DHHS) and at the Centers for Disease
Control and Prevention (CDC), and the Office of Research on Women’s Health was
formed at the National Institutes of Health (NIH). Furthermore, in an effort to articulate
a women’s health research agenda, NIH proposed its own definition of women’s health,
as follows:
Diseases or conditions unique to women or some subgroup
of women; diseases or conditions more prevalent in
women; diseases or conditions more seri.ous among women
ore some subgroup of women; diseases or conditions for
which the risk factors are different for women or some
subgroup of women; and diseases or conditions for which
the intenentions are differentfor women or some subgroup
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ofwomen.
While the complete omission of an emphasis (or even mention) of health and
wellness is apparent in this definition, it does make clear that today’s perception of
women’s health has evolved beyond the realm of reproduction, at least for many health
professionals and health-related organizations. But a more complete and integrated
perspective of women’s health involves more than simply extending beyond reproductive
matters. Such a perspective must: concede that health is not just a matter of disease
absence, but also involves psychological and social well-being; understand gender-based
social and class inequalities as precursors for women-specific health issues, as health as a
product of biological, cultural, psychological and social factors; acknowledge the
multiple roles of women and their diverse health issues during different life stages, all of
which involve, but do not revolve around, reproductive matters; and recognize the need
for health promotion and disease prevention strategies. Ideally, such a perspective also
would recognize access to health care as a fundamental right, and not a privilege of class,
gender or race.
Ongoing Issues in Wmnen’s Health
One of the greatest concerns in regard to the current state of women’s health is the
fragmentation of women’s health care services. This concern has led American women’s
health care to be dubbed "a patchwork quilt with gaps," referring to the gaps in health
services that have resulted from the separation of women’s reproductive health care from
all other women’s health care.v This is evidenced by the multiple sites and sources of
health care that women utilize to meet their various needs, such as reproductive health
clinics, public health department clinics, hospital emergency departments, and private
physician’s offices. Such differing sources of health care mean that women risk not only
redundancy of services when going from one provider to another, but also gaps in
services because of the lack of coordination in their health care.z’’v Varying use of
clinical screening procedures has been associated with differing physician specialties.
While physicians specializing in three areas (family/general practitioners, internists, and
obstetrician-gynecologists) provide most primary health care services to women, Bartman
and Weiss found that generalists and internists were half as likely as obstetrician-
gynecologists to perform a pelvic examination, a Papanicolaou smear, and a clinical
breast exam during a routine medical examination.’
The Advent Pap tests and Mammography
There have been great advances in women’s health over the past century. Since
1900, the average life span for American women has increased by over 30 years. While
there have been many valuable medical and scientific accomplishments that have
contributed to the improvements in women’s health, two of the most important are the
Pap test and mammography.
In 1928, a Greek-born cytologist and pathologist named George Nicholas
Papanicolaou announced a technique he had discovered to identify precancerous and
cancerous cervical cells in women.9 The technique, which we now call a "Pap smear" or
"Pap test", involves gathering cellular material from the vaginal tract and cervix and
smearing it on a glass slide, where it is microscopically examined for cellular
abnormalities. Abnormal cells found through this test may develop into cervical or
uterine cancer, but if detected early and treated promptly, it is now known that cervical
cancer is one of the most successfully treated cancers, l Though Papanicolaou’s
discovery was a tremendous medical breakthrough in women’s health, it was met with
resistance and skepticism by the medical community at large.9 Not until the 1950s did
cervical cancer screening with Pap tests become mainstream in American medicine, and
with widespread utilization came a historic drop in the incidence of cervical cancer, since
detection of precancerous lesions by the Pap test led to early treatment of the lesions, in
effect preventing the cancer. It follows that mortality due to cervical cancer also has
been drastically reducedby a full 70%since cervical cancer has a survival rate of
almost 100% if it is detected in its earliest stage, treated appropriately, and carefully
followed-up. ’
In 1913, a German surgeon, Albert Salomon, announced his attempts to detect
cancer of the breast using radiography. 2 This involved taking an x-ray of the breast and
examining the x-ray to detect abnormal masses and/or tumors in the breast tissue. Like
Papanicolaou, Salomon’s discovery of the mammogram was not widely accepted by the
general medical community at the time. However, technical improvements in the
procedure and the use of lower-dose radiation helped to mainstream mammography into
the American health care system in the 1970s. 2
Even with widespread usage, screening with mammography for the early
detection of breast cancer has long been a subject of controversy because of the perceived
risks associated with radiation. A recent review of several long-term mammography
trials questioned not only the data collection and analysis methods used in these trials, but
moreover challenged the efficacy of screening mammograms in decreasing breast cancer
mortality rates, l Many health agencies, organizations and professionals (such as the
American Cancer Society and the National Cancer Institute) have not agreed with the
findings of this review, and according to former CDC Director Jeffrey P. Koplan, routine
mammography screening remains "the best available method to detect breast cancer in its
earliest, most treatable stage--an average of 1.7 years before the woman can feel the
Unlike the Pap test, which can detect precancerous lesions that can be treated to
prevent cancer, mammography detects breast cancer itself and not its precursors. It
therefore follows that, with the number of new cancer cases being found through the
widespread use of mamm0graphy, breast cancer incidence rates have increasedby over
40% between 1973 and 1998.a However, as mammography is able to detect the disease
in its earlier stages, mortality rates have decreased; when breast cancer is diagnosed at a
local stage, its victims have a five-year survival rate of 96%.
Mammography and Pap test Screening Guidelines
Recognizing the value that both mammograms and Pap tests have in reducing
morbidity and mortality, several health agencies and organizations have produced
specific guidelines for frequency schedules of routine mammography and Pap tests.
These guidelines have been continuously revised as scientific knowledge accumulates
over time, in order to reflect the optimal screening schedule through an analysis of the
benefits and risks associated with these screening procedures.
While there is mostly general agreement in regard to Pap test screenings, an
optimal mammography screening schedule is still a matter of debate. Recommendations
for mammography for women aged 50 years and older are basically similar; most of the
controversy surrounds women age 40 49, for whom "the evidence that screening
mammography reduces mortality from breast cancer is weaker, and the absolute benefit
of mammography is smaller, than it is for older women," notes the U.S. Preventive
Services Task Force (USPSTF). Recommendations for mammography screening of
several health promotion and health care entities include:
U.S. Preventive Services Task Force: The USPSTF recommends screening
mammography with or without clinical breast examination every 1 2 years
for females aged 40 and older, ts The U.S. Department of Health and Human
Services (DHHS) endorses the recommendation of the USPSTF. 16
American Cancer Society’ ACS recommends annual mammography.
screening for women beginning at age 40. 7 The American Medical
Association and the American College of Radiology support the same
guideline. 8,9
American College of Obstetricians and Gynecologists: ACOG
recommends screening with mammography every 1 2 years for women
aged 40 49, and annually for women aged 50 and older.2
American Academy of Family Physicians" AAFP recommends
mammography every 1 2 years beginning at age 40 for high-risk women,
and beginning at age 50 for average-risk women. The American College of
Preventive Medicine recommends this guideline as well 2
Guidelines recommended for the commencement and timing schedule of Pap tests
are not nearly as numerous or varied as those for mammography. The guidelines for
cervical cancer screening are as follows"
United States Preventive Services Task Force: The USPSTF recommends
beginning Pap tests when a female first becomes sexually active, and
assumes sexual activity by the age of 18.23 Therefore, it is recommended that
Pap testing begin at age 18 or at onset of sexual activity, if earlier than age
18, and should be repeated at least every three years. Pap testing is not
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believed to be necessary for women who have had a complete hysterectomy,
in which the entire cervix was removed, unless the procedure was performed
because of cervical cancer or precancerous cells of the cervix.23’24 The
USPSTF also acknowledges that there is insufficient evidence to make a
recommendation about the age at which to discontinue Pap testing.
Recommendations for cervical cancer screening disseminated by the Institute
for Clinical Systems Improvement concur with the guidelines promulgated by
the USPSTF.74
American Cancer Society: ACS released new cervical cancer early
detection guidelines in November 2002. The organization recommends that
Pap testing begin three years after a woman becomes sexually active, but no
later than 21 years old, and that Pap tests should be continued yearly (for
traditional Pap tests) or every other year (for the newer, liquid-based tests)
until age 30. Women who reach the age of 30 and have had three
consecutive normal Pap tests may choose to be screened every 2 to 3 years,
and women 70 and older who have had three consecutive normal Pap tests,
with no abnormal tests in the past decade, may c.hoose to terminate screening.
Pap testing after a complete hysterectomy is recommended only if the surgery
was necessary because of cervical cancer or pre-cancer. These
recommendations are intended for women with no increased risk of cervical
cancer, and not for those who are at higher risk, who may need to be screened
more frequently.2
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Utilization Rates ofMammography and Pap tests
Despite continuous scientific research and technological advancement, breast and
cervical cancers continue to affect thousands of U.S. women each year. Over 99% of the
estimated 193,700 new cases of breast cancer that emerged in American in 2001 were
found in femalesevidence that breast cancer remains a very prominent women’s health
issue.26 Over 40,000 women are estimated to have died from breast cancer in the same
year. Almost 13,000 U.S. women were diagnosed with cervical cancer in 2001, and it
was the cause of 4,400 deaths. 26
The above morbidity and mortality numbers demonstrate that even with the
proven life-saving benefits of mammography and Pap tests, and with programs such as
the CDC’s National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
that aimto increase access for underserved women, there are still women who do not
receive these screening procedures at regular, timely intervals. While no screening test
has complete efficacy as to detect all early stage cancers (or precancerous lesions), the
mortality and morbidity rates for breast and cervical cancers seem to indicate not a lack
of sensitivity of the screening procedures, but rather underutilization of these services.
It should not be assumed, however, that underutilization of mammography and
Pap tests reflects the desire or intent of women who are not receiving these screenings at
the optimal recommended time schedules. Indeed, the role of practitioners who provide
primary care services to women must be taken into account when examining
mammography and Pap test utilization rates. While individuals may have every intention
of obtaining these screenings at optimal time intervals, many times the ultimate decision
lies with the health care provider, as it is the provider who must order and/or perform
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such screening tests. Some women may not be aware of breast and cervical cancer
screening guidelines, and therefore may rely on their physician (or other medical care
provider) to be aware of and follow recommended guidelines for preventive screening
procedures. And as noted previously, physicians in some specialties are less likely to
perform preventive screening tests during routine medical examinations than others. So
when studying the factors that affect utilization patterns of breast and cervical cancer
screenings, it cannot be overlooked that physician behaviors can be equally as influential,
or perhaps even more so, as a woman’s individual intentions, characteristics and
circumstances.
Resemch has identified several subgroups of women that have been associated
with underutilization of mammography and Pap testing. Older age has been shown to
have a negative association with mammogram usage,27-32 which is quite disconcerting,
given that breast cancer risk increases with age’ 77% of new breast cancer cases and 84%
of deaths from the disease occur in women age 50 and older.? Pap test usage has also
been shown to decrease as a woman’s age increases,27’?-’46 even though incidence of
invasive cervical cancer augments with age. When looking at race and ethnicity,
studies show that Hispanic/Latina women underutilize both mammography’2’36 and Pap
tests.2V,o,3 Studies also show that Black/African American women utilize Pap tests more
than any other racial or ethnic group,27’32’34’35’37 and recent data show that there is little to
no significant difference in rates of mammography usage for Black/African American
women when compared to mammography rates of White/Caucasian Women.32’76 A small
number of studies have suggested that women who are not married are at increased risk
for underutilizing Pap tests.3’34
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Socioeconomic factors also have historically played a role in the use of these
preventive screening measures. Lower income and less education have been highly
27,30,31,33,34 Lesscon’elated with decreased rates of mammogram and Pap test utilization.
research has investigated the influence of employment status on preventive screening
utilization, and there are conflicting results between those that do. In 1988, Rodney
Hayward and his colleagues found that women not participating in the labor force were
27 but in 1993 a modest association wasslightly more likely to have had a recent Pap test,
found between employment and increased use of mammography and Pap tests by
Eugenia Calle and her fellow researchers.3
When looking at variables that deal with health and health care issues, a clearer
picture emerges. Poor health status, lack of a usual doctor or medical care provider, and
lack of health care coverage have consistently been associated with underutilization of
both mammography and Pap teStS. 27’31’32’34’35"38 Of all influencing variables, health
insurance coverage seems to be one of the strongest predictors of clinical preventive
service utilization.
The CDC’s National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) was established to help underserved women gain access to mammography
and Pap tests. By offering these screenings to low income, older, racial/ethnic minority
and uninsured females at little to no cost, the NBCCEDP has provided services to almost
1.5 million women in the United States. But as evidenced by the research, a large
proportion of underserved women remain unscreened. In fact, the CDC acknowledges
that the NBCCEDP reaches only 15% to 20% of the population eligible for this
38program.
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Aside from the demographic, socioeconomic, and health-related variables listed
above, there are numerous other factors that can influence a woman’s use of
mammograms and Pap tests. Type of residence area (i.e., rural versus urban),
transportation issues, time constraints and the social influence of others are just a few of
the possible mitigating factors that have been explored in past studies, or are being
examined in current research.
bnproving Utilization Rates: Healthy People 2010
The medical and public health professions have long been concerned about the
underutilization of mammography and Pap tests by certain subgroups of women. This
concern protnpted the inclusion of objectives focused on increasing mammogram and
Pap test usage by U.S. women in Healthy People 2000, the national health promotion and
disease prevention initiative founded in 1990. Healthy People 2000 emphasized disease
prevention and early detection, and outlined a "lO-year strategy for improving the
Nation’s health by the end of the 20th century".4 The desire to increase mammogram
and Pap test usage continues with Healthy People 2010, Healthy People 2000’s
successor, which contains the following objectives:
Objective 3-11a: Increase the proportion of women aged 18 years and
older who have ever received a Pap test from the baseline rate of 92% in
1998 to the target rate of 97% by 2010;
Objective 3-11b: Increase the proportion of women aged 18 years and
older who received a Pap test within the preceding 3 years from the
baseline rate of 79% in 1998 to the target rate of 90% by 2010; and
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Objective 3.13: Increase the proportion of women aged 40 years and older
who have received a mammogram within the preceding 2 years from the
baseline rate of 68% in 1998 to the target rate of 70% by 2010.
These objectives reflect the federal government’ s acceptance of the USPSTF’s
guidelines for mammography and Pap tests. They are also measures that states and
localities can compare with their own statistics, and thereby gauge the success of current
health promotion and disease prevention efforts aimed at increasing breast and cervical
cancer screening in their areas.
STUDY GOAL AND OBJECTIVES
The overall goal of this study is to identify individual demographic,
socioeconomic, and health-related factors that are associated with differing utilization
rates of mammograms and Pap tests for female respondents 0f the Manchester Health
Survey 2001. Characteristics and circumstances of the respondents as consumers of
health care services are focused on in this analysis, even though physician behaviors and
practices are acknowledged to influence utilization outcomes as well. The analysis
further seeks to identify the main predictors of the underutilization of mammograms and
Pap tests while controlling for other influencing variables, such as age and income, by
simultaneously examining demographic, socioeconomic, and health-related variables that
may lead to differing outcomes (i.e., appropriate utilization in accordance with
recommended guidelines as opposed to underutilization). The guidelines promulgated by
the USPSTF for breast and cervical cancer screening are used for this analysis. Overall
mammography and Pap test utilization rates for the Manchester population are compared
with the Healthy People 2010 target rates to ascertain the progress in local preventive
health screening behaviors. Thus, the specific research questions for this analysis are:
1) Which demographic, socioeconomic and health-related factors affect
mammography and Pap test utilization rates of adult Manchester female
respondents?
2) Which demographic, socioeconomic and health-related variables can be used




3) Are the routine breast and cervical cancer screenings utilization rates of adult
Manchester female respondents similar to the Healthy People 2010 target
rates?
The findings of this study may not only be applicable to the town of Manchester,
Connecticut, but perhaps also to other towns with similar demographic profiles.
Implications from this analysis may be used to evaluate current health promotion and
disease prevention programs aimed at increasing mammography and Pap test utilization
rates.
METHODS
Data from the Manchester Health Survey 2001 are used in this analysis of factors
influencing utilization of breast and cervical cancer screenings. This standardized,
structured telephone survey was conducted fiom March through May 2001 by the
Manchester Health Department in Manchester, Connecticut, as part of the town’s
Community Health Needs Assessment process.
Manchester Community Health Needs Assessment
One of the essential services of public health is to monitor the health status of the
community. Such monitoring aims to identify community health problems, information
that is necessary for effective health planning. During the mid-1990s, the town of
Manchester, Connecticut recognized this need and began establishing an ongoing process
to monitor the community’s health.4 The process commenced by acknowledging the
importance of assessing the health needs of the town’s residents, as well as the need to
increase awareness about health behaviors and concerns. The assessment effort officially
began in January 1998 with the creation of the Manchester Community Health Needs
Assessment Committee, which was composed of community residents, business leaders
and town department officials. Committee membership was broadly based to represent
the diverse interests and population of Manchester.4
The committee selected 21 priority health concerns, defined measures for each of
those concerns, and designed a report card format for reporting on them.42 The report
card format included a discussion of each indicator and its meaning and value to the
community; available and statistically reliable data for measuring each indicator; and
interventions available which produce measurable resu|ts.42
18
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Need for a Survey
Much of the existing data collected on the Manchester Community Health Needs
Assessment indicators had been obtained through reliable secondary sources, such as the
State of Connecticut Department of Public Health’ s Division of Vital Statistics.42 While
this information was very useful, most of it was not reported specifically for the town of
Manchester, as most data was categorized on a regional, multi-town basis. Therefore, the
health department decided to administer an anonymous population survey of Manchester
residents by telephone in order to gather additional, first-hand information on a number
43of health issues and concerns.
Survey Instrument
While some of the questions included in the Manchester Health Survey 2001
specifically dealt with issues particular to the town of Manchester, many were adopted
from other surveys, such as the CDC’s Behavioral Risk Factor Surveillance Survey
(BRFSS) and the National Center for Health Statistics’ National Health Interview Survey
(NHIS).45 These surveys are administered nationally on an continual basis, and have
demonstrated validity and reliability. The survey questionnaire created by the
Manchester Health Department (hereafter referred to as the health department) was
developed over a period of approximately two years, with several pilot tests and revisions
taking place in the process. In all, the survey instrument was a lengthy 27 pages long and
took 15 to 45 minutes to complete over the telephone; only persons who stated they were
18 years and older were asked to participate.4 While both males and females were asked
to participate in the survey for an accurate assessment of the town’s health needs, all male
respondents were excluded for the present analysis.
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While there are drawbacks to conducting surveys over the telephone (such as non-
coverage, non-response and total survey error), the advantages of using telephone surveys
for cross-sectional population studies are numerous. Advantages include wide coverage
of a geographic area due to the amount of people that can be reached by telephone; the
relative completeness of household telephone coverage, especially in the Northeast; the
opportunity for quality control over the data collection process; cost efficiency; and the
speed with which data can be gathered.46 Additionally, when organized and administered
carefully and correctly, telephone interviews can achieve standardized results relatively
free of bias and enor, as is the goal of any good survey.47 The CDC’s protocol for
administering the BRFSS was adapted for use with the Manchester Health Survey 2001,
and provided organized guidelines for training interviewers, setting up the calling facility,
adhering to a calling schedule and the replacement of telephone numbers.
Sampling Method & Frame
The target population for the survey consisted of the adult, civilian, non-
institutionalized population of Manchester, Connecticut. Using a directory of telephone
numbers was judged to be insufficient for compiling a sample for the survey, because of
the need to sample households with unlisted telephone numbers as well as those with
listed numbers.45 Instead, a list of random telephone numbers with Manchester prefixes
was purchased from a commercial list vendor, Survey Sampling, Inc., based in Fairfield,
Connecticut. The list consisted of approximately 9000 telephone numbers, randomly
generated by a computer and screened by the vendor for non-working and known
business numbers, as the health department sought to survey only household residences.
The sample frame (i.e., the list of active, non-business Manchester telephone numbers
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randomly generated by Survey Sampling, Inc.) was stratified according to the prefix of
the telephone number. Telephone numbers from each stratum were selected fiom the
sample frame in proportion to the rate of telephone numbers in Manchester with that
specific prefix, resulting in a list of telephone numbers with prefixes at a rate proportional
to the frequency of the prefix in the entire sample fi’ame.4s In other words, there was a
higher proportion of telephone numbers in the sample list that had prefixes that occur
more frequently in Manchester (such as "645" or "646"). This type of sampling, called
proportionate stratified random sampling, was chosen over simple random sampling
because, in theory, it reduces sampling en’or by more accurately reflecting the entire
sample frame of active Manchester telephone numbers.4 In effect, the sample becomes
more representative of non-institutionalized, adult Manchester residents living in
households with a telephone.
In order to further randomize the sample, the health department decided to
employ a strategy for within-household random selection of respondents. This was done
to protect against selection bias in the survey, by which those respondents who were
available at the time of the call (typically females and older adults) or who were more
willing to be interviewed (usually younger and well-educated persons) would be
overrepresented in the survey.46 The last recent birthday method of respondent
selection was used, in which the interviewers asked to speak with the Manchester resident
living in the household who was 18 or over and had the last (or most recent) birthday.45
This selection procedure was used to avoid bias that could occur from respondent
selection being left to the interviewer and the individual who answered the telephone;
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research shows that this method of respondent selection yields the requested respondent
being interviewed most (75% to 80%) of the time.4
Survey Implementation
The survey field period took place from mid-March until early May 2001, with
calls taking place seven days a week.4s As noted above, BRFSS protocol was followed
by interviewers and supervisors, which specified the calling hours (1:00 pm- 9:00 pm
Sunday Friday, 10:-00 am 2:00 pm Saturday) and the procedures for repeated calling
of telephone numbers (telephone numbers were called up to 15 times if interviewers
continuously received a busy signal or ring with no answer).49 The survey was
administered with paper and pencil, and answers were checked, coded and entered into a
computer data base. Selected interviewers performed these data entry activities following
the survey field period, entering information from the paper surveys into the CDC’s
Epilnfo Version 6.04 software program. Each survey was entered twice to ensure the
entered data was correct. The survey coordinator and supervisors reviewed each
worker’s data entry accuracy to further ensure quality control.4s
Manchester, Connecticut is a town with a population of approximately 55,000
residents. Of the total population, 42,401 are adults age i8 and over, of which 53.6%
(n=22,727) are female.4 Approximately 5000 telephone numbers were called for the
Manchester Health Survey 2001, and interviewers attempted to speak with the adult
Manchester resident living in the household who had the last (or most recent) birthday
(see Sampling Method & Frame section above for details). However, many of these
telephone numbers were out of service or fax lines (20%) or were business numbers
(11.1%), even though the telephone number sample was prescreened for business and
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nonworking numbers by the sample vendor.5 Some of the telephone numbers called
were constantly busy or rang without ever being answered after 15 calling attempts
(16.6%), reached residences outside of Manchester (15.3%), or reached a residence in
which language differences or physical/mental impairment were barriers to selecting the
eligible respondent and completing the survey (1.1%). Excluding these telephone
numbers and using only those numbers in which an eligible respondent was reached
through the random respondent selection process, a total of 1614 numbers were called
and yielded 1004 completed surveys. By excluding nonworking, business, fax, out-of-
town, and never-answered telephone numbers, as well as telephone numbers that reached
residences with language, physical, or mental barriers, the overall response rate for
individuals eligible to participate in the survey was 62.2%.4 The percentage of missing
data for each of the survey questions used in this study ranges from 0% (for the question
"Is there someone that you think of as your personal doctor or medical care provider?")
to 16.2% (n = 94) for the question "What is your total annual household income from all
sources?"). Missing data were excluded from the analysis, and only data from female
respondents were used in this study.
Analysis of Util&ation Patterns
While the health department did not conduct this survey specifically for the
purpose of determining utilization rates of routine mammography and Pap test screening
by the town’s adult female residents, the information gathered from the survey provides a
significant amount of data on the subject, therefore lending itself for analysis in this
study. It must be noted, however, that the data gathered by the survey is the result of an
observational study, and may not be readily generalizable to other populations.
24
Independent and Dependent Variables
Nine dichotomous demographic, socioeconomic, and health-related variables
were examined to determine their influence on mammography and Pap test utilization.
Variables were dichotomized to avoid small numbers in each variable subgroup;
explorations of the data using independent variables with multiple levels reduced the
number of cases in each subgroup because of the relatively small sample size (data not
shown).
Demographic variables used in this analysis include: Age (40 to 49 years versus
50+ years for mammography, and 18 to 49 years versus 50+ years for Pap test);
Race/Ethnicity (White/Caucasian versus Other, which includes Black/African American,
Hispanic/Latina, multiracial and any other race, including Asian/Pacific Islander and
American Indian/Alaska Native); and Marital Status (Married versus Not Mamed, which
includes separated or divorced, widowed and single). Socioeconomic-related
independent variables used in this analysis consist of: Education Level (Did not complete
high school or general equivalency diploma (GED) versus Completed high school or
GED or more); Employment Status (Employed versus Not Employed, which includes
disabled and retired); and Annual Household Income (Under $50,000 versus At or Above
$50,000). Finally, the three health-related independent variables include: Self-Reported
General Health Status (Excellent, Very Good or Good versus Fair or Poor); Health Care
Coverage Status (Has some form of health care coverage versus Does not have health
care coverage); and Usual Doctor or Medical Care Provider (Has usual doctor or medical
cm’e provider versus Does not have usual doctor or medical care provider).
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Three outcome measurements (dependent variables) for mammography utilization
were used in the univariate analysis portion of this study: ever had a mammogram, had a
mammogram during the past 12 months, and overall utilization of routine mammography
screenings (using the current USPSTF screening guidelines recommending that women
age 40 years and older have a mammogram every one to two years). The three outcome
measurements for Pap test utilization employed in the univariate analysis include: had a
Pap test screening during last routine medical examination (RME), had a routine Pap test
in the past 12 months, and overall utilization of routine Pap test screenings (using the
current USPSTF guidelines recommending that women who have an intact cervix and
who are sexually active and/or age 18 and older obtain a Pap test at least every three
years).
While the health department sur.vey contained questions with numerous answers
for respondents to choose from, some adjustments needed to be made for the purposes of
data analysis in this study. Among categorical and ordinal variables with a number of
choice levels that survey participants were provided to answer questions, such levels
were collapsed and made bivariate in order to increase the number of respondents in each
of the subgroups. The categories of each subgroup within the variables were selected in
large part for their compatibility with previous studies pertaining to mammography and
Pap test utilization, and do not necessarily reflect an optimally balanced distribution of
subjects in each subgroup.
In regard to the annual household income, this variable was split into subgroups
with income boundaries that differ from the more commonly used parameters of annual
household income below $25,000 versus annual household income of $25,000 or more.
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No significant differences in utilization of breast and cervical cancer screening were
found when comparing respondents with incomes below versus above the $25,000
income figure (data not shown). In order to investigate any differences that may occur
outside these standard income limits, the variable was then recategorized to compare
utilization rates of lower- and middle-income respondents (with annual household
incomes less than $50,000) to utilization rates of respondents at higher income levels
(with annual household incomes of $50,000 or more).
The measurements of Pap test usage differ from the mammography usage
measurements due to the context in which Pap test information was elicited by the
survey. Respondents were asked about Pap tests as a part of clinical preventive services
obtained during routine medical examinations. Specifically, respondents were asked
when they had their last RME, and whether or not their last RME included a Pap test.
These questions are structured differently from the mammography questions on the
survey, which asked if the respondent ever had a mammogram, and if so, the length of
time since the respondent’s last mammogram. Please note that the information collected
on Pap test utilization was asked within the context of a routine medical examination and
the information on mammography utilization was not. The variation in survey questions
regarding mammography and Pap test utilization was caused by the differing sources of
the questions: mammography questions were identical to those used on the BRFSS, and
the Pap test questions were designed by the health department to elicit information on
screening procedures performed during RMEs. Although the survey interviewers did
explain to respondents that routine gynecological exams were considered RMEs, a
number of respondents may have distinguished between routine examinations by a
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gynecologist and routine examinations by an internist or family physician, thereby
separating reproductive health care from all other health care. This is related to the
fragmentation of women’s health care, noted in an em-lier section of this paper, and
possibly could have affected the results of the Pap test questions. One should also take
notice that questions were asked specifically about routine screening Pap tests during
routine medical examinations, and not about diagnostic Pap tests performed because of a
problem or abnormality, as the survey was primarily concerned with routine clinical
preventive services and not diagnostic tests and services.
Sample Characteristics
A total of 579 adult female Manchester residents participated in the Manchester
Health Survey 2001, ranging in age from 18 to 89 years. Proportions for demographic,
socioeconomic, and,health-related characteristics for the entire sample are presented in
Table 1.
Only those women who identified themselves as 40 years ol age and older (n
351) were included in the sample for the mammography analyses. Respondents stating
they were under age 40 at the time of the survey (n 208) and respondents refusing to
provide their age (n 20) were excluded from mammography analyses. This was done
so the sample would reflect utilization rates of women who have reached the age at which
most health agencies and organizations recommend routine mammography screenings
should commence for individuals without elevated risk. Demographic, socioeconomic,
and health-related data for respondents used in the mammography analyses are presented
in Table 2.
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TABLE 1" Demographic, Socioeconomic, and Health-Related Characteristics of
All 579 Females in the Study Sample, Manchester Health Survey 2001




























Usual Medical Care Provider
n= 579
18- 39 years old
40- 49 years old










Less than HS diploma or GED
Completed HS diploma or GED
Some college or technical school
l:our or more years of college
Employed Full Time
Employed Part Time


























Excellent, Very Good or Good
Fair or Poor
Has health care coverage
Does not have health care coverage






(0 missing) Does not have usual medical care provider 6,9
* Missing data includes "Don’t know" and "Ret;’ts’to answer" resPo’e as Well as data misig du to
human error. Note that percentages may not sum to exactly 100% due to rounding.
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TABLE 2: Demographic, Socioeconomic, and Health-Related Characteristics of 351
Age 40+ Females in the Study Sample, Manchester Health Survey 2001

























Usual Medical Care Provider
n = 351
40- 49 years old 33.0
50 64 years old 38..8






Divorced or Separated 23.4
Single 13.0
Widowed 19.0
Less than HS diploma or GED
Completed HS diploma or GED
Some college-or technical school
Four or more years of college
Employed Full Time
Employed Part Time














Excellent, Very Good or Good
Fair or Poor
Has health care coverage
Does not have health care coverage






(0 missing) Does not.h_awolsual medi,,cal care pr,ov,!der 5,.4
Missing data includes "Don’t know" and "Refuse to answer" responses, as well as data missing due to
human error. Note that percentages may not sum to exactly 100% due to rounding.
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There were a number of exclusion criteria that reduced the number of respondents
eligible for Pap test analyses as well. The responses of all 579 survey participants were
used when calculating rates of having a Pap test during last RME, but a number of these
women (n=14) stated that the Pap test question was not applicable to them. As this
response may have been stated because these respondents did not have a cervix (due to a
complete hysterectomy), Pap tests indeed may not have been applicable to these women,
and thus they were excluded from the remaining Pap test analyses. An additional,
significant number of cases (n = 130) also had to be excluded from the annual Pap test
and overall Pap test utilization analyses because respondents stated that they had their last
RME within the past one or two years and did not receive a Pap test during the
examination. Individuals stating that they had their last RME within the past twelve
months, but no Pap test was included, may have had another, previous RME within the
past 12 months that may or may not have included a Pap test, and so could not be used
in the annual Pap test analysis. In regard to overall utilization rates, respondents stating
they did not have Pap test during their last RME within the past one or two years, may
have had a RME prior to their most recent one that may have included a Pap test and was
within the previous three-year time frame. However, since data was only collected on the
most recent RME in this survey, overall utilization rates for this group of women could
not be calculated. In reality, these individuals may have had a routine Pap test within the
past three years, so rates of utilization in accordance with the USPSTF’s guidelines could
not be judged in these cases. For simplification purposes, all 130 of these respondents
were excluded from annual and overall Pap test utilization analyses. With eight
additional respondents excluded because they were unsure of (or unwilling to answer)
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when they had their last routine Pap test, the number of women used in the annual Pap
test and overall Pap test utilization analyses totaled 427. Table 3 contains demographic,
socioeconomic, and health-related data for respondents used in the annual Pap test and
overall utilization analyses.
Data Analysis
SPSS Version 11.0.1 for Windows, a statistical analysis and data management
software system, was used to calculate flequencies and to perform chi-square tests for the
univariate analyses, examining the utilization rates of mammography and Pap test
screening by each of the nine independent variables. As noted above, to avoid small cell
numbers in variable categories with rare outcomes, categories were collapsed to form
dichotomous variables for statistical analysis. SPSS 11.0.1 was also used to calculate the
odds ratios and 95% confidence intervals for the univariate analyses. Those variables
which obtained a significance level, or p-value, of 0.05 or less for the chi-square tests are
listed in Tables 4 and 6.
The SAS System for Windows, Version 8, was used to perform multiple logistic
regression analyses on the data. Logistic regression allows for the analysis of the relative
contributions of independent variables on the likelihood of underutilizing routine
mammography and Pap test screenings. Regression models were tested using both the no
selection and the forward stepwise selection methods. Odds ratios (ORs) and 95%
confidence intervals (CIs) were also obtained using SAS to estimate the relative risk of
overall underutilization according to the screening guidelines. No weighting procedures
were used to alter the data in this sample.
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TABLE 3: Demographic, Socioeconomic, and Health-Related Characteristics of 427
Females Used in Annual Pap test and Overall Pap test Utilization Analyses,
From the Manchester Health Survey 2001 Sample


























Usual Medical Care Provider
n =427
18 39 years old 41.3
40- 49 years old 22,2
50 64 years old 23.9






Divorced or Separated 20.5
Single 26.4
Widowed 9.4
Less than HS diploma or GED
Completed HS diploma or GED
Some college or technical school





















Has health care coverage
Does not have health care coverage
94.8
5.2
Has usual medical care provider 93.9
(0 missing) Does not ,h,,,,av,e usu,,,a! medical _care PrOvider 6.1
* Missing data includes "Don’t know" and "Refuse to answer" responses, as well as data missing due to
human error. Note that percentages may not sum to exactly 100% due to rounding.
RESULTS
Mammography Underutilization
Overall, 351 of the 579 women surveyed stated that they were 40 years of age or
older, and these women were used in the mammography utilization analysis. Of these
respondents, 6.8% (n=24) said they had never had a mammogram, and 26.2% (n=92) said
they had not received a mammogram within the past 12 months. When looking at
underutilization of routine mammography screening, 14.5% (n=51) of respondents in this
sample had not received a mammogram within the past two years, as recommended in the
USPSTF’s guidelines.
As can be seen in Table 4, the independent variables associated with statistically
significant differences in rates of ever having a mammogram are annual household
income, general health status, health care coverage status, and usual doctor or medical
care provider (MCP). Annual household income (p=0.032) and general health status
(p=0.034) seem to have had a considerable effect on lifetime mammography rates.
Respondents with annual household incomes under $50,000 were more likely to never
have received a mammogram (9.3%) than those with an income of $50,000 or more
(2.7%). Of participants reporting excellent, very good or good health status, 5.8% had
never been screened with mammography, as opposed to 14% of participants who
reported fair or poor health status who have never received this screening procedure.
A marked difference in rates of lifetime mammography use was seen with two
variables, health care coverage status and whether or not one has a usual doctor or
MCP. Only 6.3% of respondents with some form of health care coverage reported
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TABLE 4" Characteristics Associated with Decreased Mammography Utilization*




Never Had a Mammogram
Annual Household Income Under
$50,000
Fair or Poor General Health Status
No health care coverage
No usual doctor or MCP
9.3 3.658 1.040, 12.863
14.0 2.662 1.043, 6.794
25.0 4.937 1.243, 19.609
25.0 5.167 1.528, 17.476
No Mammogram in Past 12 Months
Not Manied (Divorced/Separated,
Widowed or Single)
Annual Household Income Under
$50,000
Fair or Poor General Health Status
No health care coverage
No usual doctor or MCP
33.9 2.286 1.374, 3.801
32.9 2.082 1.174, 3.693
39.6 1.983 1.050, 3.747
66.7 5.833 1.713, 19.868
68.8 6.681 2.254, 19.804
No Mammogram in Past 2 Years
Not Manied (Divorced/Separated,
Widowed or Single)
Annual Household Income Under
$50,000
No health care coverage
No usual doctor or MCP
19.6 2.417 1.253, 4.666
18.8 2.319 1.090, 4.935
58.3 9.068 2.757, 29.830
43.8 5.003 1.773, 14.118
nly vba-s-i-afrences (p < 0.05)in-mammographyutilization
are listed in table.
never having a mammogram, as opposed to a full 25% of those who do not have
coverage (p--0.013). Approximately these same proportions applied to those who had a
usual doctor or MCP versus those who did not, with 6.1% of the former group and 25%
of the latter group reporting that they have never had a mammogram (p=0.004).
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A number of variables proved to be associated with significant differences in
having a mammogram within the past 12 months. Women who were not married had a
higher likelihood of not receiving a mammogram during the past year than women who
were roamed (33.9% versus 18.3%, p=0.001). Having a higher annual household income
was a factor in annual screening, since 32.9% of survey participants with incomes below
$50,000 had not received a mammogram during the past year, and a lesser 19.1% of those
with incomes at or above $50,000 had not (p=0.011). Women with fair or poor health
were less likely than women reporting excellent, very good or good health to have
received an annual mammogram" 39.6% of the former group were not screened during
the past year, as opposed to 24.8% of the latter group (p=0.033).
A large difference was also seen between annual mammogram rates of those with
and without health care coverage; 25.5% of respondents with coverage failed to be
screened in the past year, in contrast with the majority (66.7%) of respondents lackin,,
health care coverage (p=0.002). Annual mammography rates also were found to be
associated with the usual doctor or MCP variable, as almost 69% of women lacking a
usual doctor or MCP had not had mammogram during the past 12 months, but only 25%
of those with a usual doctor MCP had not (p<0.001).
Women in the study 40 years of age and older were considered to be
underutilizing mammography if they reported having their last mammogram more than
two years ago, as recommended in the USPSTF mammography screening guidelines.
Again, as seen with lifetime and annual mammography usage, having some form of
health care coverage and having a usual doctor or MCP maintained associations with
mammography underutilization. Respondents lacking health care coverage had an
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underutilization rate of 58.3%, and those with health care coverage had an
underutilization rate of only 13.4% (p<0.001). While 13.5% of survey participants with a
usual doctor or MCP did not have a mammogram within the past two years, 43.8% of
those without a usual MCP did not (p=0.001). There were notable discrepancies in rates
of underutilization between respondents with annual household incomes at or above
$50,000 (9.1%) and those with lower incomes (18.8%, p=0.026). And as with having an
annual mammogram, women who were single, widowed, separated or divorced were
more likely to have had no mammogram in the past two years (19.6%) than those who
were married (9.2%, p=0.007).
Several other variables also affected utilization rates of mammography, but the
effects did not reach statistical significance in the univariate analyses. However, these
differences should still be noted. Women ages 40 -49 were more likely than those 50
years and older to never have had a mammogram (10.5% versus 5.2%, p=0.065), as were
White/Caucasian women (7.6%) when compared to women included in the Other
race/ethnicity category (0%, p=0.130). But respondents in the Other race/ethnicity
category were more likely to have skipped a mammogram in the past year (37%) than
those in the White/Caucasian category (25.9%, p=0.209). Survey participants having less
than a high school diploma or GED were more likely to have skipped their annual
mammogram (37%) than those participants with more education (25.9%, p-0.212). As
for overall mammography utilization in accordance with recommended guidelines, only
3.7% of females in the Other race/ethnicity group had no mammogram in the past two
years, as compared with 16% of females in the White/Caucasian group (p=0.087).
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Additionally, those with fair or poor health were more likely to underutilize
mammography (22.9%) than those with better health status (13.6%, p=0.093).
Multiple logistic regression was used to identify predictors of mammography
underutilization. After simultaneously controlling for all nine variables in the regression
model, the analysis using no selection method revealed three variables that had
statistically significant likelihood ratio chi-square values when using a 0.10 level of
significance (which is customary for this step in the multiple logistic regression
procedure): health care coverage, usual doctor or MCP, and race/ethnicity (see Table 5).
When considering odds ratio estimates, lack of a usual doctor or MCP seemed to remain
predictive of mammography underutilization (OR=6.056, CI=1.549, 23.679), but lack of
health care coverage had a wide CI that included the number 1 when following the rules
of rounding (OR=5.194, CI=l.046, 25.795). Other race or ethnicity seemed to show a
negative relationship with underutilization; in other words, the likelihood of obtaining a
mammogram during the past two years seemed to increase with Other race/ethnicity
(OR=0.117, CI=0.011, 1.256). But a CI that included the number 1 also limited this
finding, and so race/ethnicity, just like health care coverage, may have little predictive
value for mammography utilization when controlling for other confounding variables.
Results of the logistic regression model run with forward stepwise selection (data
not shown) demonstrated three variables with statistically significant likelihood ratio chi-
square values when evaluating predictors of mammography underutilization: lacking a
usual doctor or MCP (p=0.0281), lacking health care coverage (p=0.058 l), and not being
married (p=0.0345). While the usual MCP variable had a wide but acceptable CI for its
odds ratio (OR=4.044, CI=1.162, 14.077), and the marital status variable had a more
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TABLE 5: Results of Mammography Underutilization Analysis
Using Multiple Logistic Regression with No Selection Method,
Manchester Health Survey 2001
Variable LeV:i::Of Odds 95’%CnfidenCeSignificance* Ratio Interval
No usual doctor or MCP 0.0096 6.056 1.549, 23.679




0.0764 0.117 0.011, 1.256
* Significant at 90%, or 0.10.
narrow CI but nearly included the number 1 (OR=2.321, CI=1.063, 5.065), the CI for the
health care coverage variable both was wide and included the number 1 in this model
(OR=4.119, CI=0.953, 17.811). Even so, a number of observations keep the health care
coverage variable from being excluded as predictive of mammography utilization. These
observations include the fact that health care coverage was associated with very
significant differences in the univariate analyses, that health care coverage is a suspected
predictor in both logistic regression models, and that non-coverage has been shown to
reduce mammography usage in other studies. Such findings make it possible to suspect
that health care coverage status still may have been a predictor of mammography
underutilization in this sample, in spite of the variable’s confidence intervals.
Pap test Underutilization
Of the entire sample overall, 73.5% (n=422) of women surveyed stated that their
last routine medical examination (RME) included a Pap test; 24% (n=138) of the sample
did not have a Pap test at their last RME, and 2.5% (n=14) said the question was not
39
applicable to them. As noted earlier, these 14 women were excluded from the remaining
Pap test analyses, along with another 138 respondents whose routine Pap test utilization
could not be judged because of survey limitations (see the Sample Characteristics section
of this paper).
Of the 427 remaining survey participants eligible for analysis, 12.9% (n=55) said
that they did not have a Pap test during a RME in the past 12 months. The vast majority
of respondents proved to be utilizing routine Pap tests according to the USPSTF
guidelines, with only 4.7% (n=20) of respondents not receiving a Pap test during a RME
in the past three years.
Table 6 shows the five independent variables associated with significant
differences in the rates of women having had a Pap test during their last RME. Older
age, less education, and not being currently employed were all positively associated with
having no Pap test during the last RME with a high degree of statistical significance (p<
0.001). Whereas 16.9% of females surveyed under age 50 reported that they did not
receive a Pap test at their last RME, 34.8% of women age 50 and older reported the same.
Not completing high school or GED greatly decreased the likelihood of having had a Pap
test during the last RME, with over half (51.4%)of females with limited education stating
they did not have this test performed at their last RME, and only 22.9% of respondents
with more education reporting the samea difference of almost 29%. Twenty percent
(20%) of employed women were not screened during their last RME, but 34.3% of
women who were not employed went unscreened.
Annual household income was also a notable independent variable, as lack of a
Pap test during the last RME was 26.7% for women with a lesser household income
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TABLE 6: Characteristics Associated with Decreased Pap Test Utilization*







No Pap Test during Last RME
Age 50 Years and Older
Did not complete high school or GED
Not Employed
Annual Household Income Under
$50,000
Fair or Poor General Health Status
34.8 2.629 1.758, 3.930
51.4 3.565 1.782, 7.132
34.3 2.088 1.397, 3.121
26.7 1.625 1.033, 2.556
39.7 2.206 1.253, 3.884
No Pap Test in Past 12 Months (during last RME)
No health care coverage
No usual doctor or MCP
50 8.159 3.342, 19.917
42.3 5.950 2.572, 13.764
Not Adherent to Recommended Pap Test Guidelines
No health care coverage
No usual doctor or MCP
22.7 7.608 2.476, 23.378
26.9 10.996 3.934, 30.732
only var-i-’ie;assodiaiedwi--significant differences (p < 0.05)in Pap testi]JzafionJi: listed in tbie.
(under $50,000 annually), and 18.3% for those in the higher income bracket of $50,000
or more annually (p=0.035). General health status was the fifth independent variable
significantly affecting these rates, with 23% of respondents reporting their health was
excellent, very good or good going unscreened at their last RME, as opposed to
39.7% of women in fair or poor health (p=0.005). No differences were observed between
subgroups with differing health care coverage status, or between subgroups that did and
did not have usual doctors or MCPs.
Results for univariate analysis of factors influencing differing rates of annual Pap
testing and for overall utilization of routine Pap testing showed only two variables of
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significance, which were identical for both outcome measures: health care coverage
status and usual doctor or MCP. While 10.9% of respondents with some form of health
care coverage had not received a Pap test during a RME in the past twelve months, those
without coverage reported not receiving a Pap test at a rate of 50% (p<0.001). Those
respondents having a usual doctor or MCP were more likely to report a Pap test during
the past year than those who did not have a usual doctor or MCP, with only 11% of the
former group going unscreened as compared to 42.3% of the latter group (p<0.001).
Respondents without health care coverage maintained significantly higher rates of
underutilization of Pap test screening according to recommended guidelines than those
with coverage (22.7% versus 3.7%, p<0.001). Also, those respondents lacking a usual
doctor or MCP demonstrated higher rates of underutilization than those who had a usual
doctor or MCP (26.9% versus 3.2%, p<0.001).
As with mammography use, there were some variables associated with smaller
differences in Pap test utilization that did not reach statistical significance, but are
noteworthy nonetheless. While 34.5% of respondents without health care coverage
reported no Pap test during their last RME, a lesser 23.6% of covered respondents
reported the same (p=0.184). Additionally, women with annual household incomes
under $50,000 were slightly more likely to underutilize Pap test screenings when
compared with USPSTF guidelines (6.7%) than were women with incomes at or above
this figure (2.5%, p=0.068).
The multiple logistic regression procedure was used to identify predictors of Pap
test underutilization, as it was with mammography utilization. When all nine
independent variables were forced into a regression model with no selection method, five
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had statistically significant likelihood ratio chi-square values using a 0.10 significance
level" usual doctor or MCP, health care coverage, race/ethnicity, employment status, and
income level (see Table 7). When considering odds ratios, lack of a usual doctor or MCP
remained predictive of Pap test underutilization (OR -12.763, CI- 3.062, 53.194), as did
lack of health care coverage (OR=8.919, CI= 1.637, 48.601), but both had very wide CIs.
Other racb/ethnicity showed a negative relationship with underutilization (OR=0.057,
CI=0.004, 0.844), indicating that Other race/ethnicity is a predictor of increased
utilization of Pap tests. This is consistent with the findings of other studies that look at
race/ethnicity and Pap test utilization. 27,32,34,35,37 Finally, while the employment and
income variables had statistically significant likelihood ratio chi-square values, their
confidence intervals included the number 1 (OR=0.152, CI=0.021, 1.101 for not being
employed; OR=0.309, CI=0.075, 1.268 for annual household income less than $50,000).
In addition, these variables demonstrated a negative relationship with Pap test
underutilization, indicating that not being employed and having a lower annual household
income increased utilization. Such findings seem to be counter-intuitive and are not
supported by previous research. For these reasons, the employment and income variables
were not considered to be predictors of Pap test underutilization.
When analyzing the results of the logistic regression model run with forward
stepwise selection (data not shown), the three variables determined to be predictive in the
first modellacking a usual doctor or MCP, lacking health care coverage, and
White/Caucasian race/ethnicity emerged with significant likelihood ratio chi-square
values (p=0.0010, p=0.0073, and p=0.0687, respectively). However, the CI for the
race/ethnicity variable contained the number 1 (OR=0.125, CI=0.013, 1.173), implying
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TABLE 7: Results of Overall Pap test Underutilization Analysis
Using Logistic Regression with No Selection Method,
Manchester Health Survey 2001
Variable Significance* Ratio Interval
No usual doctor or MCP 0.0005 12.763 3.062, 53.194





0.0372 0.057 0.004, 0.844
Not Employed 0.0623 0.152 0.021, 1.I01
Annual Household Income < 50K 0.1029 0.309 0.075, 1.268
* significant at 90’i or Oii’i
that this variable may have less predictive value than originally indicated in the first
model, which controlled for the effects of other variables. The CIs for lacking a usual
doctor or MCP (OR=8.198, CI=2.336, 28.772) and lacking health care coverage
(OR=6.778, CI=1.676, 27.408) were wide but did not contain the number 1, and thus
could be considered as predictors of Pap test underutilization for this study.
DISCUSSION
Findings ofthe Analysis
The overall findings of this analysis are quite encouraging for female residents of
Manchester, Connecticut. A high percentage, 93.1%, of women age 40 and older
reported that they had received a mammogram at some point in their lives, and 73.2%
said that their last mammogram occurred within the past year. With 85.1% of
respondents age 40 and older having received their last mammogram within the past two
years, these women have already exceeded the mammography screening objective of
Healthy People 2010, which is to increase the proportion of women 40 and older who
have received a mammogram within the preceding two years to 70%.
Overall findings of Pap test utilization in accordance with national guidelines are
favorable as well. With over 95% of survey participants having received a Pap test
during a routine medical examination within the past three years, female residents of
Manchester have also surpassed the Healthy People 2010 objective of at least 90% of
women aged 18 years and older having received a Pap test within the preceding three
years.
Although the overall mammography and Pap test screening utilization rates of the
Manchester adult female population are high, there are still subgroups of the population
whose utilization rates are lower, as evidenced by the findings of this study. Those
respondents who lack health care coverage and those who lack a usual doctor or medical
care provider have the highest rates of overall underutilization for both cancer screening
procedures, and these two variables emerged as influential in both the univariate chi-
square analysis and the multivariate logistic regression analysis. Survey participants who
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had no health care coverage reported the lowest overall utilization of mammography
screening, with less than half (41.7%) having received a mammogram in the previous two
years, as opposed to 86.6% of participants with health care coverage. This finding is
consistent with previous studies that have found lack of health insurance to be a
significant predictor of mammography underuse.27’32’3 A lower rate of utilization can be
expected from this subgroup, given the high cost of mammography screening, and those
females with no health care coverage may not want to, or be able to, pay for the cost of
this procedure out-of-pocket. Lower rates of Pap test utilization also were found in
respondents lacking health care coverage, with approximately 77% having had a Pap test
during a routine physical exam in the past three years, as compared to 96.3% of
respondents with coverage. This finding is also supported by previous studies that have
found lower rates of Pap test screening utilization among uninsured individuals.2’32’75
Research shows that women are slightly more likely to have health care coverage
than men.’5 However, it is apparent that women who lack such coverage do not receive
life-saving breast and cervical cancer screenings at the optimal time intervals
recommended by the U.S. Preventive Services Task Force. In this sample, the overall
rate of health care coverage is 94.4%, which leaves 5.6% of respondents without
coverage and thus more vulnerable to decreased mammography and Pap test utilization.
Health care coverage increases with age in this sample, as 9.3% of women under 40 had
no health care coverage and 3.7% of women 40 and over were not covered. This
increased coverage among older women can be expected, as they become eligible for
Medicare with age. Breast cancer, being the second most common cancer in women, is
likely to develop in some of these individuals whether or not they are being screened
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according to the guidelines. But the cancer would likely be discovered at a more
advanced stage if these women were unable to receive mammograms every one to two
years as recommended by the USPSTF. And tragically, with later-stage diagnosis comes
a higher mortality rate. The same would be true for the 22.7% of non-insured women in
the sample who have not received a routine Pap test in the past three years, as
recommended by the USPSTF. If these women were to remain vulnerable to delays in
routine Pap testing, they would be at greater risk of later diagnosis if cervical cancer were
to develop. And as with breast cancer, later-stage diagnosis of cervical cancer is
associated with a higher mortality rate. If we were to extend these findings to the entire
adult female Manchester population (and beyond, if appropriate), they would suggest that
many cases of illness and death could be prevented by assisting women without
healthcare, coverage obtain timely routine mammograms and Pap tests. And it is evident,
through the findings of this analysis and many others, that increased utilization is
associated with by increasing the rate of health care coverage.
Respondents who reported having no usual doctor or medical care provider also
fell short of the Healthy People 2010 target rates for both breast and cervical cancer
screening utilization. In the entire sample, 6.5% of the re.spondents lacked a usual doctor
or MCP; among those age 40 and older, the rate is 5.4%. Of women 40 years and older
with no usual doctor or MCP, 56.2% received a mammogram in the past 24 months,
leaving 43.8% who did not. As for Pap testing, about 73% of respondents lacking a
regular health care provider had a Pap test within the past three years, but approximately
27% did not. These findings of decreased mammography and Pap test utilization in
persons without regular MCPs concur with findings in several published studies.32’34’35
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The multivariate regression analysis shows that lacking a usual MCP is a predictor of
underutilization independent of health care coverage status, and perhaps it is a regular
provider’s coordination of care, as well as a steady provider’s encouragement to maintain
one’s health, that increases utilization of cancer screening procedures in those who have a
usual doctor or MCP.
Although it did not prove to be as strong a predictor of underutilization as having
a usual MCP or having health care coverage, not being married seemed to have some
association with decreased mammography use in this analysis. This finding concurs with
research conducted by Eugenia Calle and her colleagues, as well as Linda Martin and
her associates,4 but such a relationship between mammography use and marital status is
not widely recognized. Being unmarried was associated with lower mammography
utilization in the univariate and forward stepwise regression analyses, but did not present
as a predictor in the regression model where all variables were forced simultaneously to
control for confounding. While this does not mean marital status had no influence on
mammography utilization, it may signify that there could be some other factor associated
with marital status, and not marital status itself, that influenced mammography utilization
races.
Of interest is the finding of race/ethnicity as a predictor in the logistic regression
model for underutilization of routine Pap test screenings. In the univariate analysis, the
difference between Pap test utilization rates for the race/ethnicity subgroups is small,
with 5.5% of White/Caucasian respondents and 1.4% of Other race/ethnicity respondents
underutilizing Pap test screenings according to recommended guidelines (p=0.134).
However, when the race/ethnicity variable is included with all other factors in the logistic
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regression model with no selection method, as well as in the forward stepwise selection
model, White/Caucasian race/ethnicity emerged as a predictor for Pap test
underutilization. Past research has shown that, in general, Black/African American
women do utilize Pap testing more appropriately than other races and ethnicities, but
research has also demonstrated a higher rate of both mammogram and Pap test
underutilization among Hispanic/Latino ethnicity and "other" races.’2 Because of the
relatively small sample size in this study, the Other category of race/ethnicity includes
Black/Afiican American, Hispanic/Latino, multiracial and other race or ethnicity, and
this combination may have influenced the findings regarding this variable. In reality,
there may be an even greater difference in Pap test utilization between Black/African
American females and White/Caucasian females in this study. More in-depth research
on race and ethnicity factors should be pursued before stating the degree of predictive
value that race/ethnicity has on routine Pap test utilization for adult females in
Manchester.
Limitations ofthe Analysis
The results Of this analysis are limited due to a number of factors, and should be
interpreted with caution. The data was gathered based on a self-reporting survey, and is
therefore subject to recall bias, as certain groups or individuals may have been able to
recall the preventive screening procedures they have received more accurately. Because
the survey instrument was administered over the telephone, there could be effects of non-
coverage error, as 5% of households in the Northeast do not have telephones and thus
were not included in the sampling frame.6 There also was a percentage of eligible
respondents who refused to participate in the survey, which may have led to response
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bias, as those persons who refused to participate in the survey may have been
systematically different than those who completed the survey.
Additionally, the true rate of Pap test utilization may differ from the findings in
this analysis. As noted earlier in this paper, the Pap test utilization questions were asked
within the context of the respondent’s last routine medical examination. Data was not
collected on Pap tests obtained outside a RME, since such a test may be more likely to be
due to a specific condition or problem, and thus would function not as a screening test but
rather a diagnostic test. Since no data was collected on screening procedures obtained
outside the respondent’s last routine medical examination, it was impossible to conclude
yearly Pap test and overall Pap test utilization information. So as to not over- or
understate cervical cancer screening utilization, some of these cases had to be excluded
from analysis, and it is possible that these exclusions may have affected the Pap test
utilization findings for this sample.
CONCLUSIONS
Implications ofthe Findings
The results of this analysis show that in this random sample of adult women in
Manchester, Connecticut, overall utilization rates of routine mammography and Pap test
screenings have exceeded the Healthy People 20 l0 target rates. However, findings als0
show subgroups of women who remain substantially below the target rates. Women with
no health care coverage and women with no usual doctor or medical care provider have
the lowest rates of overall utilization for both mammography and Pap test guidelines.
These two factors, lack of health care coverage and lack of a usual doctor or medical care
provider, seem to consistently and significantly predict underutilization for both
screening procedures. Additionally, not being married may increase the risk of receiving
mammograms at a less than optimal screening schedule, and White/Caucasian
race/ethnicity may contribute to receiving Pap tests at less frequent intervals than
recommended.
Having a usual doctor or medical care provider increases a woman’s chances of
obtaining both breast and cervical cancer screening procedures as recommended in
national preventive health service guidelines. Perhaps this increased rate of appropriate
utilization is a result of the coordination of care that comes with having a personal
physician or other MCP. Such an effect may also be due to an ongoing emphasis on
preventive health care by a usual health care provider.
Since income did not demonstrate much strength as an independent predictive
factor, women with low breast and cervical cancer screening utilization rates do not
necessarily have low household incomes. Therefore, they may not meet the financial
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qualifications often required for free or low-cost mammograms and Pap tests through
programs such as the CDC’s Breast and Cervical Cancer Early Detection Program. This
finding reflects the ongoing need for comprehensive health care coverage in the United
States, regardless of an individual’s age, sex, income or general health status.
Next Steps
The matter of universal health care coverage for all Americans is fraught with
political and social controversy. However, it seems flom the findings of this studyas
well as many othersthat providing comprehensive health care coverage, with a
designated primary medical care provider for each individual, may be a significant step in
increasing the appropriate utilization of routine mammography and Pap test screenings.
Such an increase in utilization may, in effect, reduce morbidity and mortality from breast
and cervical cancer, and significantly contribute to the health of American women.
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